EMA Human Scientific Committees' Working Parties with Patients' and Consumers' Organisations (PCWP) and Healthcare Professionals' Organisations (HCPWP) joint meeting

• Date:
  Wednesday, 15 March 2017, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This joint PCWP/HCPWP meeting discusses the European Medicines Agency's 2016 annual report, its interactions with patients, consumers, healthcare professionals and their organisations, its work plans for 2018/19, the outcome of the Committee for Medicinal Products for Human Use pilot project, European Antibiotic Awareness Day. It also provides an update on topic groups including biosimilars, the 10 year report on conditional marketing authorisations, regulators' and health technology assessment bodies' related activities and feedback from the scientific committees.

Documents

Agenda - EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (15 March 2017)

AdoptedReference Number: EMA/69326/2017

Minutes - EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (15 March 2017)

AdoptedReference Number: EMA/182189/2017

List of participants of the EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (15 March 2017)

Reference Number: EMA/101021/2017

Presentation - Interaction with healthcare professionals (I.Silva, EMA)

Presentation - Interaction with patients and consumers (N. Bere, EMA)

Presentation - Satisfaction survey on involvement of patients, consumers and healthcare professionals during 2016 (N. Bere, EMA)

Presentation - Topic Groups: lessons learnt and way forward (I. Silva, EMA)

Presentation - Involvement of patients: Outcome of pilot project (N. Bere, EMA)

Presentation - European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe (D. Monnet, ARHAI)

Presentation - BMWP-Interested Party Meeting 2017 (C. Vleminckx, EMA)

Presentation - European Commission multi-stakeholder workshop: Biosimilar Medicinal Products, 5 May 2017 (H. Juhà¡sz, European Commission)

Presentation - EMA activities related to synergies between regulators and HTA bodies (M. Berntgen, EMA)

Presentation - Feedback from CHMP (F. Ventura, EMA)

Presentation - Feedback from COMP (D. O'Connor, COMP)

Presentation - Feedback from CAT (K. Breen, EMA)

Presentation - Feedback from PDCO (J. Taminiau, PDCO)

Presentation - The added value of Twitter (K. Plass, EAU)

Presentation - Report from conference "Shortages of human medicines in the European Union" (F. Houà¿ez, EURORDIS)

Presentation - EMA communication perception survey (E. Scanlan, EMA)